基因组UIP检测阳性后间质性肺疾病的进展
本研究为美国七家学术医疗中心接受临床指征支气管镜gUIP检测患者的汇总回顾性分析,共纳入192例有随访数据者(gUIP阳性104例、阴性88例)。阳性gUIP分类与18个月无进展生存期(PFS)降低相关但未达统计学显著(HR 1.58,95%CI 0.86-2.92;p=0.14),两组FVC年下降幅度差异亦无统计学意义。
要点
- gUIP阳性者18个月PFS风险比为1.58,但95%CI跨1、p=0.14,未达统计学显著。
- gUIP阳性与阴性组FVC年下降分别为-101.8 mL与-73.2 mL,组间差异无统计学意义。
- 在支气管镜诊断评估人群中,gUIP分类未显示与IPF样进展表型相关。
核心结论
- 在接受支气管镜诊断评估的多中心间质性肺疾病队列中,gUIP分类与PFS或纵向FVC下降速率的差异无关。
研究设计与样本
- 美国七家学术医疗中心接受临床指征诊断性支气管镜并行gUIP检测患者的汇总回顾性分析。
- 238例连续接受gUIP检测的患者中,192例有可用随访数据并纳入分析,包括104例gUIP阳性与88例gUIP阴性。
- 采用Cox比例风险回归评估gUIP分类与18个月PFS的关联,并用联合回归模型比较FVC纵向变化。
主要发现
- 多变量分析中,阳性gUIP分类与PFS降低相关(HR 1.58,95%CI 0.86-2.92;p=0.14),但未达统计学显著。
- gUIP阳性者FVC年均变化为-101.8 mL(95%CI -142.7--60.9 mL;p<0.001)。
- gUIP阴性者FVC年均变化为-73.2 mL(95%CI -115.2--31.1 mL;p<0.001)。
- 两组FVC年变化差异为28.7 mL(95%CI -83.2-25.9 mL;p=0.30)。
关键数值与推荐
- PFS定义为自gUIP检测起至全因死亡、肺移植、FVC相对下降≥10%或末次可用FVC测量时删失的时间。
- gUIP阳性组与阴性组FVC年变化差异的95%CI为-83.2-25.9 mL,p=0.30。
临床怎么用
- 对于支气管镜诊断评估中gUIP阳性的ILD患者,不应仅凭gUIP分类预判其将出现更快的IPF样进展。
- gUIP分类结果需结合临床、影像与随访综合解读,本队列未显示其与PFS或FVC下降速率的独立关联。
局限性
- 为回顾性汇总分析,仅纳入有随访数据的192例,可能存在选择偏倚。
- PFS关联未达统计学显著,FVC变化组间差异亦无统计学意义,结果需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A genomic classifier for usual interstitial pneumonia (gUIP) has been shown to predict histological UIP with high specificity, increasing diagnostic confidence for idiopathic pulmonary fibrosis (IPF). Whether those with positive gUIP classification exhibit a progressive, IPF-like phenotype remains unknown. METHODS: A pooled, retrospective analysis of patients who underwent clinically indicated diagnostic bronchoscopy with gUIP testing at seven academic medical centres across the USA was performed. We assessed the association between gUIP classification and 18-month progression-free survival (PFS) using Cox proportional hazards regression. PFS was defined as the time from gUIP testing to death from any cause, lung transplant, ≥10% relative decline in forced vital capacity (FVC) or censoring at the time of last available FVC measure. Longitudinal change in FVC was then compared between gUIP classification groups using a joint regression model. RESULTS: Of 238 consecutive patients who underwent gUIP testing, 192 had available follow-up data and were included in the analysis, including 104 with positive gUIP classification and 88 with negative classification. In multivariable analysis, positive gUIP classification was associated with reduced PFS (hazard ratio 1.58, 95% CI 0.86-2.92; p=0.14), but this did not reach statistical significance. Mean annual change in FVC was -101.8 mL (95% CI -142.7- -60.9 mL; p<0.001) for those with positive gUIP classification and -73.2 mL (95% CI -115.2- -31.1 mL; p<0.001) for those with negative classification (difference 28.7 mL, 95% CI -83.2-25.9 mL; p=0.30). CONCLUSIONS: gUIP classification was not associated with differential rates of PFS or longitudinal FVC decline in a multicentre interstitial lung disease cohort undergoing bronchoscopy as part of the diagnostic evaluation.
引用
- Chaudhary S, Weigt SS, Ribeiro Neto ML, et al. Interstitial lung disease progression after genomic usual interstitial pneumonia testing. Eur Respir J. 2023. PMID: 36549706. doi:10.1183/13993003.01245-2022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。